These foci are commonly in the superior pulmonary veins; this is an important factor in the electrophysiologic approach to atrial fibrillation, known as pulmonary vein isolation. Less commonly ...

The definition of symptomatic improvement after pulmonary vein isolation (PVI) is controversial. We assessed primarily the usefulness and predictive accuracy (PA) of AF (atrial fibrillation ...

Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, today announced the initiation of the ...

The study subjects were 51 consecutive patients with highly symptomatic permanent (n = 25) or persistent (n = 26) atrial fibrillation resistant to, or intolerant of, drug therapy. Atrial ...

"Our results provide conclusive evidence for the benefit of pulmonary vein isolation ablation in individuals with symptomatic atrial fibrillation, putting concerns about a substantial placebo ...

Atrial fibrillation is the most common cardiac ... initiated by repetitive discharges originating from the pulmonary veins.

"Second, PFA may yield more durable lesions, thereby reducing pulmonary-vein reconnections ... growing body of evidence supporting the use of PFA for the treatment of atrial fibrillation." "It shows ...

Pulse Biosciences is developing nsPFA technology for cardiac ablation to treat AFib and for ablating benign thyroid nodules.

The following is a summary of “Right atrial reservoir strain as an early predictor of pulmonary hypertension development in ...

One of AI’s most immediate impacts is in screening and identifying patients who may have asymptomatic or paroxysmal AF, those ...

Aurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA) to ...